In a large German study, an association of NAFLD (based on ultrasonorography and ALT elevations) with lower FT4, but not with lower FT3 or higher TSH levels was documented [138]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.